Drug Detail

Information about Avapritinib or Regorafenib

Generic Name
Avapritinib or Regorafenib
IND
Brand Name (US)
Manufacturer
Drug Type
Delivery
Oral
Approval Status
Indications
Overall Strategy
KIT and PDGFRA protein based
Strategy
Block KIT/PDGFRA
Drug Category
KIT/PDGFRA inhibitor + D842V inhibitor

This drug pair is in a phase 3 comparison trial for 3rd line treatment of resistant GIST. See the individual drug entries for avapritinib or regorafenib for details about each drug.